Ashford Capital Management Inc has filed its 13F form on November 15, 2024 for Q3 2024 where it was disclosed a total value porftolio of $733 Million distributed in 102 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Axon Enterprise, Inc. with a value of $34.7M, Cellebrite Di Ltd. with a value of $31.8M, Ligand Pharmaceuticals Inc with a value of $31.1M, Vanguard Total Stock Market Et with a value of $28.7M, and Tyler Technologies Inc with a value of $25.3M.

Examining the 13F form we can see an increase of $57M in the current position value, from $676M to 733M.

Ashford Capital Management Inc is based out at Wilmington, DE

Below you can find more details about Ashford Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $733 Million
Technology: $193 Million
Healthcare: $133 Million
Financial Services: $104 Million
ETFs: $79.2 Million
Industrials: $63.8 Million
Consumer Cyclical: $54.1 Million
Real Estate: $53.1 Million
Basic Materials: $22 Million
Other: $30.6 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 102
  • Current Value $733 Million
  • Prior Value $676 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 15, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 52 stocks
Track This Portfolio

Track Ashford Capital Management Inc Portfolio

Follow Ashford Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.